JP2013500739A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013500739A5 JP2013500739A5 JP2012523432A JP2012523432A JP2013500739A5 JP 2013500739 A5 JP2013500739 A5 JP 2013500739A5 JP 2012523432 A JP2012523432 A JP 2012523432A JP 2012523432 A JP2012523432 A JP 2012523432A JP 2013500739 A5 JP2013500739 A5 JP 2013500739A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- nucleic acid
- antibody
- disease
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL200202 | 2009-08-02 | ||
| IL200202A IL200202A0 (en) | 2009-08-02 | 2009-08-02 | Novel proteins |
| PCT/IL2010/000621 WO2011016026A2 (en) | 2009-08-02 | 2010-08-02 | Novel proteins |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015047903A Division JP5833780B2 (ja) | 2009-08-02 | 2015-03-11 | 新規タンパク質 |
| JP2015155720A Division JP2015212302A (ja) | 2009-08-02 | 2015-08-06 | 新規タンパク質 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013500739A JP2013500739A (ja) | 2013-01-10 |
| JP2013500739A5 true JP2013500739A5 (https=) | 2013-09-12 |
Family
ID=42263570
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012523432A Pending JP2013500739A (ja) | 2009-08-02 | 2010-08-02 | 新規タンパク質 |
| JP2015047903A Expired - Fee Related JP5833780B2 (ja) | 2009-08-02 | 2015-03-11 | 新規タンパク質 |
| JP2015155720A Pending JP2015212302A (ja) | 2009-08-02 | 2015-08-06 | 新規タンパク質 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015047903A Expired - Fee Related JP5833780B2 (ja) | 2009-08-02 | 2015-03-11 | 新規タンパク質 |
| JP2015155720A Pending JP2015212302A (ja) | 2009-08-02 | 2015-08-06 | 新規タンパク質 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8647632B2 (https=) |
| EP (2) | EP2985035A1 (https=) |
| JP (3) | JP2013500739A (https=) |
| KR (1) | KR101623355B1 (https=) |
| CN (1) | CN102596247B (https=) |
| AU (1) | AU2010280368B2 (https=) |
| CA (1) | CA2769001C (https=) |
| IL (3) | IL200202A0 (https=) |
| IN (1) | IN2012DN00879A (https=) |
| SG (2) | SG178097A1 (https=) |
| WO (1) | WO2011016026A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140155324A1 (en) * | 2011-08-08 | 2014-06-05 | Two To Biotech Ltd. | Novel peptides and uses thereof in therapeutic methods |
| SG11201605354WA (en) * | 2014-01-02 | 2016-07-28 | Two To Biotech Ltd | Novel polypeptides |
| CN104262468B (zh) * | 2014-09-28 | 2017-01-18 | 新乡医学院 | 一种葡萄糖转运蛋白抑制多肽及其制备方法、应用 |
| CN112920293A (zh) | 2015-03-05 | 2021-06-08 | 积水精细化工美国有限公司 | 用于vcm聚合的pvoh分散剂 |
| KR102713301B1 (ko) | 2015-12-11 | 2024-10-02 | 고쿠리츠다이가쿠호진 고치다이가쿠 | 췌장암 및 췌장관 내 유두상 점액성 종양의 마커 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US5286846A (en) | 1991-06-14 | 1994-02-15 | The Government Of The United States Of America As Represented By The Dept. Of Health And Human Services | Amino acid derivative and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides |
| US6551795B1 (en) | 1998-02-18 | 2003-04-22 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics |
| AU2001261513A1 (en) * | 2000-05-15 | 2001-11-26 | Braswell, Glenn A. | Composition and method for increasing testosterone levels |
| DE60117385D1 (de) | 2000-06-19 | 2006-04-27 | Uab Res Foundation Birmingham | Osteoklasten-sezerniertes chemokin und dessen anwendungen |
| AU2003900747A0 (en) * | 2003-02-18 | 2003-03-06 | Garvan Institute Of Medical Research | Diagnosis and treatment of pancreatic cancer |
| CA2583230A1 (en) | 2004-10-05 | 2006-04-20 | Oregon Health And Science University | Compositions and methods for treating disease |
| US20080248134A1 (en) | 2005-05-04 | 2008-10-09 | Auckland Uniservices Limited | Oral compositions, use and combinations of N-[2-(dimethylamino)ethyl]-2,6 dimethyl-1-oxo-1,2-dihydrobenzo[b]-1,6-naphthyridine-4-carboxamide and closely related analogues thereof |
| WO2008073303A2 (en) * | 2006-12-07 | 2008-06-19 | Switchgear Genomics | Transcriptional regulatory elements of biological pathways, tools, and methods |
-
2009
- 2009-08-02 IL IL200202A patent/IL200202A0/en unknown
-
2010
- 2010-08-02 AU AU2010280368A patent/AU2010280368B2/en not_active Ceased
- 2010-08-02 WO PCT/IL2010/000621 patent/WO2011016026A2/en not_active Ceased
- 2010-08-02 CA CA2769001A patent/CA2769001C/en not_active Expired - Fee Related
- 2010-08-02 JP JP2012523432A patent/JP2013500739A/ja active Pending
- 2010-08-02 US US13/387,392 patent/US8647632B2/en active Active
- 2010-08-02 EP EP15182357.2A patent/EP2985035A1/en not_active Withdrawn
- 2010-08-02 SG SG2012005070A patent/SG178097A1/en unknown
- 2010-08-02 KR KR1020127004449A patent/KR101623355B1/ko not_active Expired - Fee Related
- 2010-08-02 IN IN879DEN2012 patent/IN2012DN00879A/en unknown
- 2010-08-02 CN CN201080044688.3A patent/CN102596247B/zh not_active Expired - Fee Related
- 2010-08-02 SG SG10201404735VA patent/SG10201404735VA/en unknown
- 2010-08-02 EP EP10806144.1A patent/EP2461829B1/en not_active Not-in-force
-
2012
- 2012-01-26 IL IL217758A patent/IL217758A/en not_active IP Right Cessation
-
2015
- 2015-03-11 JP JP2015047903A patent/JP5833780B2/ja not_active Expired - Fee Related
- 2015-07-23 IL IL240134A patent/IL240134A/en not_active IP Right Cessation
- 2015-08-06 JP JP2015155720A patent/JP2015212302A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Liu et al. | The chemokine CCL1 triggers an AMFR-SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosis | |
| AU2014317035B2 (en) | IL-18 binding protein (IL-18BP) in inflammatory diseases | |
| US12173055B2 (en) | N-terminal epitopes in amyloid beta and conformationally-selective antibodies thereto | |
| Cavone et al. | Increase in the level of proinflammatory cytokine HMGB1 in nasal fluids of patients with rhinitis and its sequestration by glycyrrhizin induces eosinophil cell death | |
| US20090253632A1 (en) | Therapeutic peptides and method | |
| CN106164675B (zh) | 检测人类骨膜蛋白的新型测定 | |
| JP2013500739A5 (https=) | ||
| WO2016141334A2 (en) | Compositions and methods for diagnosing and treating autoimmune diseases | |
| AU2024284360A9 (en) | Tnf inhibitor combination therapies | |
| EP2838559B1 (en) | Combination therapy of anti-mif antibodies and glucocorticoids | |
| WO2014165866A2 (en) | Methods for immune-based diagnosis, prevention and personalized treatment of narcolepsy | |
| WO2011038689A1 (zh) | 人类新细胞因子VSTM1-v2及其应用 | |
| EP4310099A1 (en) | Pharmaceutical composition for ameliorating acute lung injury and acute worsening of pulmonary fibrosis | |
| EP4007772A1 (en) | Antibodies to candida and uses thereof | |
| CN102307894B (zh) | 螨过敏原之变体及其用途 | |
| CN119390843A (zh) | 抗tl1a抗体及其制备方法和应用 | |
| Matsuno et al. | Increased serum ADAM8 concentration in patients with drug-induced eosinophilic pneumonia-ADAM8 expression depends on a the allergen route of entry | |
| KR20170098941A (ko) | 인간 dpp-4를 검출하기 위한 검정법 | |
| WO2014181273A1 (en) | Methods for treating inflammatory bowel disease | |
| US7754207B2 (en) | Methods of treating pulmonary fibrosis | |
| US20230416381A1 (en) | Methods for treating or preventing acute respiratory distress syndrome | |
| Zheng et al. | Clinical and genetic characteristics in maternally inherited diabetes and deafness (MIDD) with mitochondrial m. 3243A> G mutation: A 10-year follow up observation study of 1 family | |
| EP4573121A1 (en) | Method of selecting patients for treatment with an il-33 axis antagonist | |
| Qi et al. | The involvement of proline-rich protein Mus musculus predicted gene 4736 in ocular surface functions | |
| US20120183562A1 (en) | Secreted fxyd proteins expressed in response to epithelial tissue damage, and uses therefor |